DNMDP |
رقم الكتالوجGC62234 |
DNMDP ، وهو مثبط فسفودايستراز 3A (PDE3A) ، هو عامل فعال وسام للخلايا السرطانيةيعزز ربط DNMDP بـ PDE3A التفاعل بين PDE3A و Schlafen 12 (SLFN12)يظهر DNMDP سمية خلوية انتقائية واضحة للخلايا
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 328104-79-6
Sample solution is provided at 25 µL, 10mM.
DNMDP, a phosphodiesterase 3A (PDE3A) inhibitor, is a potent and selective cancer cell cytotoxic agent. DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12). DNMDP shows clear cell-selective cytotoxicity[1].
DNMDP (0-1000 μM; 48 hours) shows clear cell-selective cytotoxicity[1]. HeLa cells undergo apoptosis upon DNMDP treatment, indicates by caspase activity detected by a caspase-sensitive luciferase assay and by poly ADP ribose polymerase (PARP) cleavage. At a concentration of 100 nM, DNMDP specifically inhibits both PDE3A and PDE3B, weakly inhibits PDE10, and had little or no detectable effect on other phosphodiesterases[1].
[1]. de Waal L, et al. Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics. Nat Chem Biol. 2016 Feb;12(2):102-8.
Average Rating: 5
(Based on Reviews and 14 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *